Danone suitors down to a pair

• Nestle (OTCPK:NSRGY) and Fresenius are the last two potential buyers of Danone's $5.5B Medical Nutrition business still standing.
• Nestle is already a big player in the market while Fresenius says the Danone business will complement its Kabi division that makes tube and IV feeding equipment and generic infusion drugs.
• Danone will likely use the proceeds to expand its baby food and dairy businesses.
• Unsurprisingly, the parties decline to comment at this time.